Systemic shifts in cannabis policy reveal racial capitalism’s grip on drug markets and investment flows
Original framing: “As U.S. eases cannabis curbs, firms may get access to IPOs and private funding” — The Hindu
Black and Latino entrepreneurs face systemic barriers to entering the cannabis industry, including lack of access to capital, discriminatory licensing, and ongoing criminalization. Indigenous communities, who have stewarded cannabis and its relatives for centuries, are often excluded from legal markets or forced into exploitative contracts with corporations. Women, particularly women of color, are underrepresented in leadership roles despite their historical roles in cannabis cultivation and medicine. These exclusions are not accidental but the result of structural racism and colonial legacies.
The U.S.
cannabis industry’s transition from prohibition to corporate-led legalization is a microcosm of racial capitalism, where decades of racially targeted criminalization created a multi-billion-dollar market while excluding the communities most harmed by it. The focus on IPOs and private funding obscures how federal prohibition, banking restrictions, and state-level fragmentation perpetuate monopolistic control by white-owned firms, mirroring historical patterns of resource extraction and biopiracy. Globally, Indigenous and Global South communities face criminalization for traditional uses while Northern corporations profit, revealing the colonial underpinnings of 'legalization.' To disrupt this cycle, solutions must center reparative justice—through restorative licensing, decolonized trade, public banking, and cultural preservation—while challenging the neoliberal logics that prioritize investor returns over community reinvestment. The trickster’s irony lies in how the same institutions that once demonized cannabis now profit from its commodification, underscoring the need for systemic transformation over performative reform.